Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PAL who wrote (4328)	5/20/1998 1:47:00 AM
From: George T. Santamaria	Read Replies (2) of 6136

I believe that the reason the insiders are selling is that they have expiring stock options. Maybe what's wrong here is that the option plans are a bit too generous. After all I noticed that some form of dilution, probably stock options, brought the 0.45/share earnings for the recent quarter down to $0.41. Management should be generously rewarded when they work as hard as AGPH has, however, there should be incentives to keep them working hard. If the plans are too generous, they'll stop taking risks and they won't worry about what Wall St. thinks. Someone care to comment on what's going on with stock option plans? BTW, I have to laugh when a major brokerage house sets a target and does not hold themselves accountable when they miss by the country mile that both Elise Wang of PW and MS's Doug Lind have.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next